Enanta Pharmaceuticals
ENTA
#7512
Rank
โ‚น36.77 B
Marketcap
โ‚น1,274
Share price
-1.60%
Change (1 day)
73.77%
Change (1 year)

Earnings for Enanta Pharmaceuticals (ENTA)

Earnings in 2025 (TTM): -โ‚น7.34 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company's current earnings are โ‚น64.8 Million. In 2024 the company made an earning of -โ‚น8.75 Billion, an increase over its 2023 earnings that were of -โ‚น11.49 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Enanta Pharmaceuticals from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚น7.34 Billion-16.11%
2024 -โ‚น8.75 Billion-23.87%
2023 -โ‚น11.49 Billion4.39%
2022 -โ‚น11 Billion-4.4%
2021 -โ‚น11.51 Billion91.12%
2020 -โ‚น6.03 Billion-407.13%
2019 โ‚น1.96 B-78.63%
2018 โ‚น9.17 B117.97%
2017 โ‚น4.20 B-574.65%
2016 -โ‚น0.89 Billion-110.83%
2015 โ‚น8.19 B-4.5%
2014 โ‚น8.57 B-638.53%
2013 -โ‚น1.6 Billion-137.98%
2012 โ‚น4.19 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
AbbVie
ABBV
โ‚น149.59 B-2,025.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น2.919 T-37,685.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
โ‚น402.05 B-5,276.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น2.080 T-26,889.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น723.90 B-9,419.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.479 T-19,149.33%๐Ÿ‡จ๐Ÿ‡ญ Switzerland